Clot-Sucking catheter may boost heart attack outcomes

NCT ID NCT05510661

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study compares using a manual clot-removal catheter (Export) before standard balloon angioplasty versus angioplasty alone in 300 heart attack patients with completely blocked arteries. The goal is to see if removing the clot first improves blood flow and reduces in-hospital complications like heart failure or death. Results will help determine the best timing for clot removal during emergency procedures.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
Export catheter (thrombus aspiration device)
What this could lead to
If successful, this could show that removing blood clots before opening a blocked artery during a heart attack improves blood flow and reduces complications.
What could go wrong
This is a single-center trial with 300 participants, so results may not apply broadly. Previous studies on thrombus aspiration have shown mixed results, and the procedure carries risks like bleeding or vessel damage.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PRIMARY PERCUTANEOUS CORONARY INTERVENTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • National Institute of Cardiovascular Diseases

    Karachi, Sindh, 75510, Pakistan

More trials for these conditions

Other studies related to the condition(s) this trial covers.